8-K
filed June 18, 2026, 9:23 AM ET
ticker TDAC
CIK 0001926599
other material
confidence high
sentiment neutral
materiality 0.60
TDAC shareholders approve extension to June 2027; ~$27.8M redeemed at $10.70/share
Translational Development Acquisition Corp.
- Shareholders approved extending business combination deadline from June 24, 2026 to June 24, 2027 via up to 12 monthly extensions.
- Each monthly extension requires depositing the lesser of $200,000 or $0.03 per outstanding public share into the trust account.
- Holders of 2,598,697 shares exercised redemption rights at ~$10.70/share, totaling ~$27,817,434.
- After redemptions, 14,651,303 public shares remain outstanding; 16,621,609 voted for, 809,296 against on all proposals.
- Trust agreement and charter amendments filed to permit the extension and monthly deposits.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Translational Development Acquisition Corp.: Extended the deadline for consummating a business combination from June 24, 2026 to June 24, 2027, with up to twelve monthly extensions (effective 2026-06-17).
- Change
- charter amendment
- Effective
- 2026-06-17
Exact text from the filing
The Extension Amendment extends the date by which the Company must consummate a Business Combination up to twelve (12) times from June 24, 2026 to June 24, 2027, each by an additional one-month period, for a total of twelve (12) months after the Deadline Date, assuming a Business Combination has not occurred.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Translational Development Acquisition Corp. amended Trust Agreement Amendment with Continental Stock Transfer & Trust Company valued at The amendment permits the Company to extend the date by which it must consummate an initial business (effective 2026-06-17).
- Action
- amendment
- Counterparty
- Continental Stock Transfer & Trust Company
- Value
- The amendment permits the Company to extend the date by which it must consummate an initial business
- Effective
- 2026-06-17
Exact text from the filing
On June 17, 2026, in connection with the approval by its shareholders of the Trust Agreement Amendment Proposal (as defined below) at the Meeting (as defined below), Translational Development Acquisition Corp., a Cayman Islands exempted company (the “Company”), entered into an amendment (the “Trust Agreement Amendment”) to the Investment Management Trust Agreement, dated as of December 23, 2024 (the “Trust Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, as trustee (the “Trustee”). The Trust Agreement Amendment permits the Company to extend the date by which the Company must consummate an initial business combination from June 24, 2026 (the “Deadline Date”) up to twelve (12) times, each by an additional one-month period, to June 24, 2027, by providing five days’ advance notice to the Trustee prior to the applicable Deadline Date and depositing into the Company’s trust account (the “Trust Account”), for each one-month extension, the lesser of $200,
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Translational Development Acquisition Corp. shareholders approved Trust Agreement Amendment Proposal to amend the Trust Agreement to allow extension of Deadline Date with monthly deposits.
- Outcome
- passed
Exact text from the filing
The Trust Agreement Amendment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Translational Development Acquisition Corp. shareholders approved Extension Amendment Proposal to amend the Existing Charter to extend business combination deadline.
- Proposal
- charter amendment
- Outcome
- passed
Exact text from the filing
The Extension Amendment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Translational Development Acquisition Corp. shareholders approved Adjournment Proposal to adjourn the Meeting if necessary.
- Outcome
- passed
Exact text from the filing
The Adjournment Proposal was approved with the following vote: For Against Abstentions Broker Non-Votes 16,621,609 809,296 0 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.